← Back to screener

LifeMD, Inc. LFMD

Rank #1535 · Nasdaq · $0.1B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
46.8
P/E
-5.2
P/B
-12.19
ROE
235.7%
Op. Margin
-13.2%
Debt Ratio
-921%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -5.2x, P/B -12.19x. Ranks in the top 94% of the universe.

Profitability ★★★☆☆
Average

ROE 235.7%. Ranks in the top 40% of the universe.

Safety ★★★★★
Excellent

Debt ratio -921%. Ranks in the top 2% of the universe. Under 100% is generally considered a safe level.

Growth ★★☆☆☆
Average

Revenue growth of 1.5% year over year. Ranks in the top 60% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2013$0.0B$-0.0B$-0.0B$-0.0B-80.1-83
2014$0.0B$-0.0B$-0.0B$0.0B-67.6264
2015$0.0B$-0.0B$-0.0B$-0.0B-74.3-226
2016$0.0B$-0.0B$-0.0B$0.0B-21.5348
2017$0.0B$-0.0B$-0.0B$-0.0B-22.4-322
2018$0.0B$-0.0B$-0.0B$0.0B-33.473
2019$0.0B$-0.0B$-0.0B$0.0B-24.7200
2020$0.0B$-0.0B$-0.0B$-0.0B-23.2-463
2021$0.0B$-0.1B$-0.1B$-0.0B-155.0-618
2022$0.1B$-0.1B$-0.1B$0.0B-58.5106
2023$0.1B$-0.0B$-0.0B$-0.0B-36.5-289
2024$0.2B$-0.0B$-0.0B$0.0B-9.51510
2025$0.2B$-0.0B$-0.0B$-0.0B-13.2-921

← See the full screener